Skip to main content
SpringerLink
Log in

Synchronized Release of Sulpiride and Sodium Decanoate from HPMC Matrices: A Rational Approach to Enhance Sulpiride Absorption in the Rat Intestine

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. (a) To improve the absorption of sulpiride (SP) through the intestinal wall by incorporating it together with sodium decanoate (SD) into erodible matrices, designed to synchronize the release of SP and SD over different periods of time; (b) to test, in vivo the hypothesis that this simultaneous release increases SP absorption from the intestinal lumen.

Methods. Matrix tablets, possessing different erosion rates, were prepared by changing the ratios between SD and hydroxypropyl methylcellulose (HPMC). The amounts of HPMC varied from 2.5% to 17% w/w. Double layer tablets, containing similar amounts of SP, SD, and HPMC were used as nonsynchronous controls. The erosion kinetics of the tablets was assessed gravimetrically in vitro in USP basket dissolution apparatus and in vivo in the intestine of the anesthetized rat after intra-intestinal administration. SP absorption was studied after intra-intestinal administration of the different kinds of tablets to anesthetized rats, by monitoring SP blood levels. SP and SD levels in the withdrawn samples from the dissolution systems and blood were analyzed by HPLC.

Results. The controlled erosion of the tablets resulted in equal release rates of SP and SD during the initial linear phase of the process. This synchronized release lasted over different time periods depending on the relative amount of HPMC in the formulations (from 1 hour to 4 hours for 2.5 and 17 % w/w of HPMC, respectively). The synchronous matrices increased SP bioavailability after intra-intestinal administration. The increase varied from 1.4 to 2.3-fold for the slow and the fast release formulations, respectively (compared with the nonsynchronous, SD containing control formulations), indicating the ability to control both erosion rate and length of intestinal segment in which absorption is taking place.

Conclusions. SP bioavailability after intestinal administration can be improved only if SP is released together with SD along the entire intestinal route. This can be accomplished by the design of synchronous matrices capable of concomitant release of SP and SD despite the differences in their water solubility. The ability to manipulate and control the duration of the synchronous phase of the matrices makes it possible for SP to be absorbed at different parts of the intestine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. M. Ishida, Y. Machida, N. Nambu, and T. Nagai. New mucosal dosage form of insulin. Chem. Pharm. Bull. 29:810–816 (1981).

    Google Scholar 

  2. H. Bar On, E. M. Berry, A. Eldor, M. Kidron, D. Lichtenberg, and E. Ziv. Enteral administration of insulin in the rat. Br. J. Pharmacol. 73:21–24 (1981).

    Google Scholar 

  3. T. Nishihata, G. Liversidge, and T. Higuchi. Effect of aprotinin on the rectal delivery of insulin. J. Pharm. Pharmacol. 35:616–617 (1983).

    Google Scholar 

  4. I. Naasani, N. Kohri, K. Iseki, and K. Miyazaki. Improving the oral bioavailability of sulpiride by sodium oleate in rabbits. J. Pharm. Pharmacol. 47:469–473 (1995).

    Google Scholar 

  5. S. Muranishi. Modification of intestinal absorption of drugs by lipoidal adjuvants. Pharm. Res. 108–118 (1985).

  6. S. Muranishi. Absorption enhancers. Crit. Rev. Ther. Drug Carriers Sys. 7:1–33 (1990).

    Google Scholar 

  7. A. Sintov, M. Simberg, and A. Rubinstein. Absorption enhancement of captopril in the rat colon as a putative method for capropril delivery by extended release formulations. Int. J. Pharm. 143:101–106 (1996).

    Google Scholar 

  8. M. Shameem, N. Katori, N. Aoyagi, and S. Kojima. Oral solid controlled release dosage forms: role of GI-mechanical destructive forces and colonic release in drug absorption under fasted and fed conditions in humans. Pharm. Res. 12:1049–1054 (1995).

    Google Scholar 

  9. S. F. Phillips. Integration of secretory and absorptive function. Mayo Clin. Proc. 48:630–633 (1973).

    Google Scholar 

  10. M. Baluom, M. Friedman, and A. Rubinstein. The importance of intestinal residence time of absorption enhancer on drug absorption and implication on formulative considerations. Int. J. Pharm. 176:21–30 (1998).

    Google Scholar 

  11. F. Bressolle, J. Bres, and A. Faure-Jeantis. Absolute bioavailability, rate of absorption and dose proportionality of sulpiride in humans. J. Pharm. Sci. 81:26–32 (1992).

    Google Scholar 

  12. N. Kohri, I. Naasani, K. Iseki, and K. Miyazaki. Improving the oral bioavailability of sulpiride by a gastric-retained form in rabbits. J. Pharm. Pharmacol. 48:371–374 (1995).

    Google Scholar 

  13. N. Mizuno, E. Morita, M. Nishikata, D. Shinkuma, and Y. Yamanaka. Gastrointestinal absorption of sulpiride in the rat. Arch. Int. Pharmacodyn. 283:30–38 (1986).

    Google Scholar 

  14. M. Hayashi, T. Sakai, Y. Hasegawa, T. Nishikawahara, H. Tomioka, A. Iida, N. Shimizu, M. Tomita, and S. Awazu. Physiological mechanism for enhancement of paracellular drug transport. J. Control Rel. 62:141–148 (1999).

    Google Scholar 

  15. E. K. Anderberg, T. Lindmark, and P. Artursson. Sodium caprate elicits dilatation in human intestinal tight junctions and enhances drug absorption by the paracellular route. Pharm. Res. 10:857–864 (1993).

    Google Scholar 

  16. I. Lutsky, F. Aizer, and N. Mor. The Sabra rat: Definition of a laboratory animal. Is. J. Med. Sci. 20:603–612 (1984).

    Google Scholar 

  17. J. Hochman, and P. Artursson. Mechanism of absorption enhancement and tight junction regulation. J. Control Rel. 29:253–267 (1994).

    Google Scholar 

  18. E. J. van Hoogdalem, A. M. Stijnen, A. G. De Boer, and D. D. Breimer. Rate-controlled absorption enhancement of rectally administered cefazolin in rats by a glyceride mixture (MGK). J. Pharm. Pharmacol. 40:329–332 (1988).

    Google Scholar 

  19. E. J. van Hoogdalem, M. A. Hardens, A. G. de Boer, and D. D. Breimer. Absorption enhancement of rectally infused cefoxitin sodium by medium-chain fatty acids in concious rats: Concentration-effect relationship. Pharm. Res. 5:453–456 (1988).

    Google Scholar 

  20. T. Kimura, K. Sato, K. Sugimoto, R. Tao, T. Murakami, Y. Kurosaki, and T. Nakayama. Oral administration of insulin as poly-(vinyl alcohol)-gel spheres in diabetic rats. Biol. Pharm. Bull. 19:897–900 (1996).

    Google Scholar 

  21. Y. Kimura, T. Lindmark, and P. Artursson. Regulation of immediate and long term effects of the absorption enhancer sodium caprate in human intestinal epithelial (CACO-2) cells. Proceed. Intern. Symp. Control. Rel. Bioact. Mater., Kyoto, Japan, 1996.

  22. P. Colombo, R. Bettini, P. Santi, A. De Ascentiis, and N. A. Peppas. Analysis of the swelling and release mechanisms from drug delivery systems with emphasis on drug solubility and water transport. J. Control Rel. 39:231–237 (1996).

    Google Scholar 

  23. B. Tirosh, M. Baluom, T. Nassar, M. Friedman, and A. Rubinstein. The effect of Eudragit RL-100 on the mechanical and mucoadhesion properties of polycarbophil dosage forms. J. Control Rel. 45:57–64 (1997).

    Google Scholar 

  24. K. Takahashi, T. Murakami, A. Kamata, R. Yumoto, Y. Higashi, and N. Yata. Pharmacokinetic analysis of the absorption enhancing action of decanoic acid and its derivatives in rats. Pharm. Res. 11:388–392 (1994).

    Google Scholar 

  25. N. Katori, N. Aoyagi, and T. Terao. Estimation of agitation intestity in the GI tract in humans and dogs based on in vitro/in vivo correlation. Pharm. Res. 12:237–243 (1995).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Medicine, School of Pharmacy, The Hebrew University of Jerusalem, P.O. Box 12065, Jerusalem, 91120, Israel

    Muhammad Baluom

  2. Faculty of Medicine, School of Pharmacy, The Hebrew University of Jerusalem, P.O. Box 12065, Jerusalem, 91120, Israel

    Michael Friedman, Peter Assaf, Abdullah I. Haj-Yehia & Abraham Rubinstein

  3. David R. Bloom Center for Pharmacy, Israel

    Michael Friedman & Abdullah I. Haj-Yehia

  4. David R. Bloom Center for Pharmacy, Israel

    Abraham Rubinstein

Authors
  1. Muhammad Baluom
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Friedman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter Assaf
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Abdullah I. Haj-Yehia
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Abraham Rubinstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baluom, M., Friedman, M., Assaf, P. et al. Synchronized Release of Sulpiride and Sodium Decanoate from HPMC Matrices: A Rational Approach to Enhance Sulpiride Absorption in the Rat Intestine. Pharm Res 17, 1071–1076 (2000). https://doi.org/10.1023/A:1026449527891

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026449527891

Search

Navigation